Sage Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
01.05.24
/
50%
€12.59
Target price
01.05.25
€26.21
Performance (%)
-49.87%
Price
02.10.24
€6.31
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc. is performing very badly with a performance of -49.87%. This prediction currently runs until 01.05.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sage Therapeutics Inc. | -1.652% | -1.652% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at JPMorgan Chase & Co. from $29.00 to $28.00. They now have an "overweight" rating on the stock.
Ratings data for SAGE provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.63
12.07.24
12.07.24
€16.50
12.07.25
12.07.25
-41.39%
02.10.24
02.10.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.99
20.06.24
20.06.24
€21.44
20.06.25
20.06.25
-37.31%
02.10.24
02.10.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.20
26.03.24
26.03.24
€26.71
26.03.25
26.03.25
-63.78%
02.10.24
02.10.24